Newsletter​

Connecting people, advancing clinical value

[Newsletter] Vol 72. February 2026

This is Vol.72 Newsletter for February 2026. In this issue, we cover the approaching patent cliff driving a new wave of biosimilar competition, the regulator’s shift toward full-cycle support for rare...

[Newsletter] Vol 71. January 2026

This is Vol.71 Newsletter for January 2026. This issue covers the global pharmaceutical market’s shift toward metabolic diseases from 2026 and the post-GLP-1 competitive landscape, intensifying...

[Newsletter] Vol 70. December 2025

This is 70 Newsletter for December 2025. This article we focus at the growing gap between how much global pharma is investing in Korean R&D and how little Korean patients still access new...

[Newsletter] Vol 69. November 2025

This is 69 Newsletter for November 2025. This article we focus at the growing gap between how much global pharma is investing in Korean R&D and how little Korean patients still access new...

[Newsletter] Vol 68. October 2025

This is 68 Newsletter for October 2025...

[Newsletter] Vol 66. August 2025

This is 66 Newsletter for August 2025...

[Newsletter] Vol 65. July 2025

This is 65 Newsletter for July 2025...

[Newsletter] Vol 64. June 2025

This is 64 Newsletter for June 2025...

[Newsletter] Vol 63. May 2025

This is 63 Newsletter for May 2025...